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Background: In order to characterize the intracranial pressure-volume reserve
capacity, the correlation coefficient (R) between the ICP wave amplitude (A) and
the mean ICP level (P), the RAP index, has been used to improve the diagnostic
value of ICP monitoring. Baseline pressure errors (BPEs), caused by spontaneous
shifts or drifts in baseline pressure, cause erroneous readings of mean ICP.
Consequently, BPEs could also affect ICP indices such as the RAP where in the
mean ICP is incorporated.
Methods: A prospective, observational study was carried out on patients with
aneurysmal subarachnoid hemorrhage (aSAH) undergoing ICP monitoring as part of
their surveillance. Via the same burr hole in the scull, two separate ICP sensors were
placed close to each other. For each consecutive 6-sec time window, the dynamic
mean ICP wave amplitude (MWA; measure of the amplitude of the single pressure
waves) and the static mean ICP, were computed. The RAP index was computed as
the Pearson correlation coefficient between the MWA and the mean ICP for 40 6-sec
time windows, i.e. every subsequent 4-min period (method 1). We compared this
approach with a method of calculating RAP using a 4-min moving window updated
every 6 seconds (method 2).
Results: The study included 16 aSAH patients. We compared 43,653 4-min RAP
observations of signals 1 and 2 (method 1), and 1,727,000 6-sec RAP observations
(method 2). The two methods of calculating RAP produced similar results. Differences in
RAP ≥0.4 in at least 7% of observations were seen in 5/16 (31%) patients. Moreover, the
combination of a RAP of ≥0.6 in one signal and <0.6 in the other was seen in ≥13% of
RAP-observations in 4/16 (25%) patients, and in ≥8% in another 4/16 (25%) patients.
The frequency of differences in RAP >0.2 was significantly associated with the frequency
of BPEs (5 mmHg ≤ BPE <10 mmHg).
Conclusions: Simultaneous monitoring from two separate, close-by ICP sensors reveals
significant differences in RAP that correspond to the occurrence of BPEs. As differences
in RAP are of magnitudes that may alter patient management, we do not advocate the
use of RAP in the management of neurosurgical patients.© 2014 Eide et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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Monitoring of intracranial pressure (ICP) is crucial in the intensive care management of
neurosurgical patients [1-4]. The common management goal is to maintain the static
pressure parameter mean ICP <20-25 mmHg [3]. When the cardiac-induced ICP waves
are monitored as well, the goal is to keep the dynamic pressure parameter mean ICP wave
amplitude (MWA) <5 mmHg [1]. In an attempt to better characterize the intracranial
pressure-volume reserve capacity, some authors have also calculated an index measuring
the correlation coefficient (R) between the ICP wave amplitude (A) and the mean ICP
level (P), denoted RAP [5,6]. Repetitive computation of this RAP index has been used in
the surveillance of patients with traumatic brain injury (TBI), cerebral bleeds, and hydro-
cephalus [6-9]. Using the RAP index, which ranges from -1 to +1, the upper normal
threshold is +0.6 [6,8-12]. A RAP approaching +1 has hence been considered as indicative
of reduced compensatory reserve capacity, or impaired intracranial compliance.
The mean ICP is always determined against a baseline pressure (i.e. zero or reference
pressure). A major weakness of this is that the mean ICP value that is displayed to the phys-
ician or nurse becomes erroneous if this baseline pressure is spontaneously altered during
ongoing monitoring [13]. Such baseline pressure errors (BPEs) occur during clinical ICP
monitoring, and has been seen in a variety of ICP sensor types and locations from where
the ICP is recorded [13,14]. In contrast, the dynamic ICP parameters, such as the MWA
remain unaffected by BPEs as they express just changes of ICP within each heartbeat.
In a recent prospective, observational study on 16 patients with aneurysmal sub-
arachnoid haemorrhage (SAH), we reported a high frequency and severity of BPEs
[15]. Being recognized as differences in mean ICP in combination with close to identi-
cal MWA, BPEs affect the RAP index, causing the RAP to differ widely when deter-
mined from two separate ICP sensors in the same patient [16]. This is most evident
when monitoring ICP from two different types of ICP sensors [16]. The present study
was undertaken to explore the frequency and severity of differences in RAP when
using two ICP sensors of the same type. To this end, we reanalysed the continuous
ICP recordings of 16 aSAH patients enrolled in a prospective, observational study in
which we recorded the ICP from two separate ICP sensors placed in the brain tissue
via the same burr hole in the scull [15].Methods
Patients
Aneurysmal SAH patients who need continuous ICP monitoring as part of their inten-
sive care management were enrolled in the study. Their intensive care management
was not influenced by their participation.
The study was approved by The Regional Ethics Committee, REK South-East (2010/
1328B) and Oslo University Hospital (2010/16315), Oslo, Norway. Inclusion was by oral
and written informed consent, either by the patient herself/himself or by the closest
family member.Study design
A prospective, observational study design was used to determine the frequency and
severity of BPEs, and how BPEs affect scores of ICP and ICP indices. These data were
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Moreover, we compared two different methods of calculating the RAP.Monitoring and analysis of ICP
Two Raumedic NeuroVent P (Raumedic AG, Münchberg, GE) ICP sensors were
placed in the brain parenchyma via the same burr hole, either during aneurysm
surgery, or during placement of an external ventricular drain (EVD). The location of
the ICP sensors was verified postoperatively by cerebral computer tomography (CT)
scanning.
Both sensors were connected to the MPR-1 monitor (Raumedic AG, Münchberg,
GE), which in turn was connected to a laptop computer running Sensometrics Software
(dPCom AS, Oslo, Norway). The digital sampling rate of pressure signals from the two
sensors (Sensors 1 and 2) was 100 Hz. The raw data files were stored on the computer.
Recordings from the two sensors continued throughout the time period the patient was
in need of ICP surveillance.
As previously described, the ICP signals were analyzed according to the method-
ology implemented in Sensometrics Software (Figure 1) [17]. An automatic method
identifies the heartbeat-induced single ICP waves, differentiating them from the
pressure waves of other origins (noise or various artifacts). Each heartbeat-induced
single ICP wave is characterized by the following wave parameters: the amplitude
(dP), rise time (dT), and the rise-time coefficient (dP/dT) (Figure 1c). Only 6-sec
time windows containing a minimum of four cardiac-beat-induced waves were
included for further analysis. The MWA is computed in consecutive 6-sec time
window (Figure 1c). During the same 6-sec time windows, the mean ICP is deter-
mined as the sum of sample values divided by the number of samples.Calculation of RAP
The software incorporates an automatic procedure for determining the correlation
coefficient (R) between the ICP wave amplitude (A) and the ICP level (P), the RAP, dur-
ing consecutive 4-min time periods. The RAP-index is the Pearson correlation coeffi-
cient between the MWA and the mean ICP during 40 6-sec time window periods.
Computation of RAP has previously been described by others [6,12]. Since we com-
pared the RAP of two simultaneous ICP signals, the RAP of Sensors 1 and 2 were
derived from simultaneous 6-sec time windows (Figures 1a-b).
The Pearson correlation coefficient is a measure of the strength of a relationship
between two variables, ranging from -1 to +1. When one variable changes in the
opposite direction of the other, the correlation coefficient becomes negative,
whereas the correlation coefficient becomes positive when both variables change in
the same direction (Figures 1d-f ). The closer the correlation coefficient is to + or -1,
the stronger is the relationship between the two variables. The assumptions for
using the Pearson correlation coefficient during 4-min periods as performed in this
study were fulfilled: Both the mean ICP and the MWA are continuous and inde-
pendent observations that follow a normal distribution. Moreover, for intervals of
4-minute duration, the correlation coefficient between these two observations
reflects a linear relationship.
Figure 1 Illustration of the method of determining the RAP [correlation coefficient (R) between the
intracranial pressure (ICP) wave amplitude (A) and the mean ICP level (P)] in patient 2. Following
automatic identification of the cardiac induced single intracranial pressure (ICP) waves, the mean ICP and
mean wave amplitude (MWA) are determined for every consecutive 6-sec time window. Trend plots of
mean ICP and MWA determined during the same 6-sec time windows are shown for Signals 1 (a) and 2
(b) over subsequent 12 min periods (representing three 4-min periods, and 120 6-sec time windows). For Signal 1
(a) the average (± standard deviation) of mean ICP was 7.9 ± 1.2 mmHg and of MWA 4.6 ± 0.5 mmHg; while for
Signal 2 (b)mean ICP -0.9 ± 1.9 mmHg and MWA 4.4 + 0.5 mmHg (mean difference of ICP -8.8 ± 2.2 mmHg; mean
difference of MWA -0.2 ± 0.2 mmHg). In (c) one single 6-sec time window is shown, demonstrating the individual
single ICP waves, each wave being characterized by the amplitude (dP), rise time (dT), and rise time coefficient
(RT) (indicated for single wave 3). RAP is determined as the Pearson correlation coefficient between MWA and the
mean ICP during subsequent 4 min periods (representing 40 6-sec time windows). In the patients included in this
study, we compared the RAP values during identical 4-min periods for Signals 1 and 2 (referred to as method 1).
This was performed for every consecutive 4-min period. For the three consecutive 4-min periods shown in
(a) and (b), the corresponding scatter plots and RAP-values are presented in (d), (e), and (f), respectively.
The differences in RAP were associated with marked differences in mean ICP between Signals 1 and 2
whereas the MWA was close to identical.
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(i) Method 1. According to method 1, a new RAP value was calculated every 4 min
period. Hence, for every consecutive 4-min period the software determined the
Pearson correlation coefficient (RAP) values of the two ICP signals (Figures 1c-d).
The RAP scores could then be trended as shown in Figure 2.Figure 2 Trend plots of RAP [correlation coefficient (R) between the intracranial pressure (ICP) wave
amplitude (A) and the mean ICP level (P)] of Signals 1 and 2 in patient 2. For patient 2, the trend
plots of (a) RAP determined during 100 consecutive 4-min periods for signals 1 (blue line) and 2 (red line)
show marked differences (average of RAPSignal 1 0.50; average of RAPSignal 2 -0.04). The horizontal lines at
RAP 0.6 illustrate a commonly used upper normal threshold for RAP. The intracranial locations of the ICP
sensors 1 and 2 are illustrated in (b).
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updated every 6 second. Consequently, every 6 second, the ‘oldest’ averaged value
drops out and the ‘newest’ drops in. This approach was previously described by others
[18], except that in this latter study the authors used 5 min intervals and 10 seconds
windows, as compared to 4 min intervals and 6 seconds windows in the present paper.Determination of baseline pressure errors (BPEs)
BPEs were defined as differences in mean ICP in combination with close to identical
MWAs (difference between sensors <0.5 mmHg), as recently described in this journal
[15]. In this study, we determined the percentage of recording time with BPEs of given
magnitudes (5 mmHg ≤ BPE < 10 mmHg) for every patient.Results
Patients
The study enrolled a total of 16 aSAH patients, 8 females and 8 males, with median
age 58 (ranges 39 – 74) years (Table 1, left). The distances between the two ICP sensors
are presented in Table 1, right and were: axially median 11 (ranges 2-38) mm, coronally
median 8 (ranges 3-20) mm and sagitally median 9 (ranges 3-26) mm. No adverse ef-
fects of the ICP monitoring were observed.Method 1: comparison of 4-min RAP-values between signals 1 and 2
Table 2 left shows the number of 4-min RAP observations obtained in the 16 patients.
For all patients combined, 43,653 4-min RAP-values were available for analysis; median
number for the patients was 2,472 (ranges 1,090 – 5,522).ble 1 Demographic data of the 16 patients included in the study, and distance
tween Sensors 1 and 2
t Age Gender Distance between ICP Sensors 1 and 2 (mm)
Axial Coronal Sagittal
52 M 13 9 7
57 M 30 17 22
64 M 6 17 11
59 F 3 5 11
58 F 38 13 25
39 F 13 11 7
58 F 11 6 18
66 M 4 5 5
44 M 3 3 3
70 M 7 4 5
49 M 11 5 6
52 F 21 20 26
63 F 2 4 4
74 F 13 11 11
56 F 3 3 9
55 M 19 19 8
edian (Ranges) 58 (39-74) 8 F – 8 M 11 (2-38) 8 (3 - 20) 9 (3 - 26)
Table 2 Comparison of 4-min RAP-values between Signals 1 and 2
PatID N (4-min RAP observations) RAP (average + std) Differences in RAP between
Signals 1 and 2 (N,%)
Signal 1 Signal 2 0.2 0.4 0.6
1 1,850 0.23 ± 0.43 0.26 ± 0.42 483 (26%) 147 (8%) 51 (3%)
2 1,090 0.15 ± 0.36 -0.01 ± 0.36 612 (56%) 338 (31%) 179 (16%)
3 4,706 0.61 ± 0.33 0.62 ± 0.32 365 (8%) 72 (2%) 30 (1%)
4 2,119 0.36 ± 0.38 0.36 ± 0.38 200 (9%) 29 (1%) 8
5 1,651 0.60 ± 0.35 0.61 ± 0.35 53 (3%) 11 (1%) 3
6 1,119 0.42 ± 0.35 0.43 ± 0.35 187 (17%) 54 (5%) 10 (1%)
7 3,209 0.65 ± 0.30 0.68 ± 0.28 236 (7%) 83 (3%) 35 (1%)
8 3,747 0.51 ± 0.39 0.35 ± 0.41 1,311 (35%) 806 (22%) 456 (12%)
9 4,221 0.53 ± 0.40 0.61 ± 0.34 982 (23%) 506 (12%) 323 (8%)
10 3,538 0.25 ± 0.33 0.26 ± 0.33 166 (5%) 20 (1%) 11
11 1,494 0.62 ± 0.32 0.63 ± 0.31 54 (4%) 14 (1%) 4
12 3,089 0.83 ± 0.24 0.83 ± 0.25 19 (1%) 3 2
13 1,381 0.28 ± 0.34 0.32 ± 0.35 413 (30%) 113 (8%) 26 (2%)
14 2,093 0.38 ± 0.34 0.37 ± 0.35 254 (12%) 72 (3%) 31 (1%)
15 5,522 0.52 ± 0.36 0.50 ± 0.37 729 (13%) 142 (3%) 28 (1%)
16 2,824 0.38 ± 0.36 0.39 ± 0.36 393 (14%) 73 (3%) 15 (1%)
RAP: correlation coefficient (R) between the intracranial pressure (ICP) wave amplitude (A) and the mean ICP level (P).
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with marked differences in mean ICP whereas the MWAs remained close to identical
during the recording.
Simultaneous 4-min RAP scores (determined according to method 1) from Signal 1
and Signal 2 are presented in Table 2. While Table 2, middle, lists the RAP scores
(mean and ± standard deviation) for each patient, Table 2, right presents differences in
RAP between the two signals that were ≥ 0.2, ≥0.4, and ≥0.6, respectively. Major differ-
ences (≥0.4) in RAP were seen in 5 (31%) of 16 patients, including patients 1, 2, 8, 9,
and 13 (Table 2, right). The trend plots of RAP of the two signals are visualized for
subjects 2, 8, and 9 in Figures 2a, 3a, and 4a, respectively. The locations of the ICP
sensors for these three patients are shown on CT scans in Figures 2b, 3b, and 4b,
respectively.
Table 3 presents the portion of 4-min observations wherein RAP was <0.6 in both
signals (left), ≥0.6 in both signals (middle) and <0.6 in one signal and ≥0.6 in the other
(right). The combination of a RAP of <0.6 in one signal and ≥0.6 in the other was seen
in ≥14% of scores in 4/16 (25%) patients (patients 2, 8, 9 and 13), and in ≥9% of obser-
vations in another 4/16 (25%) patients) (patients 3, 6, 7, and 15).Method 2: comparison of 6-sec RAP-values between signals 1 and 2
The 6-sec RAP observations of the 16 patients are shown in Table 4. A total of
1,727,000 6-sec RAP values were analyzed; median number for the 16 patients was
97,922 (ranges 42,162 – 220,276). Table 4, right shows differences in RAP between the
two signals that were ≥0.2, ≥0.4, and ≥0.6, respectively. Major differences (≥0.4) in RAP
were seen in 5 of 16 patients (31%), including patients 1, 2, 8, 9, and 13 (Table 4, right).
Figure 3 Trend plots of RAP [correlation coefficient (R) between the intracranial pressure (ICP) wave
amplitude (A) and the mean ICP level (P)] of Signals 1 and 2 in patient 8. For patient 8 the trend plots
of (a) RAP determined during 100 consecutive 4-min periods for signals 1 (blue line) and 2 (red line) show
marked differences (average of RAPSignal 1 0.64; average of RAPSignal 2 0.16). The horizontal lines at RAP 0.6
illustrate a commonly used upper normal threshold for RAP. The intracranial locations of the ICP sensors 1
and 2 are shown in (b).
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to identical results, as illustrated by the percentage of differences in RAP between
signals 1 and 2 ≥ 0.4.
Table 5 presents the portion of 6-sec observations wherein RAP was <0.6 in both sig-
nals (left), ≥0.6 in both signals (middle) and <0.6 in one signal and ≥0.6 in the other
(right). The combination of a RAP of <0.6 in one signal and ≥0.6 in the other in ≥8% of
Figure 4 Trend plots of RAP [correlation coefficient (R) between the intracranial pressure (ICP) wave
amplitude (A) and the mean ICP level (P)] of Signals 1 and 2 in patient 9. For patient 9 the trend plots
of (a) RAP determined during 100 consecutive 4-min periods for signals 1 (blue line) and 2 (red line) show
marked differences (average of RAPSignal 1 0.17; average of RAPSignal 2 0.59). The horizontal lines at RAP 0.6
illustrate a commonly used upper normal threshold for RAP. The intracranial locations of the ICP sensors 1
and 2 are shown in (b).
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further illustrates that the two different methods of calculating the RAP gave similar
results regarding the percentage of observations where RAP was <0.6 in one signal and
≥0.6 in the other.
Table 3 Proportion of 4-min observations with RAP <0.6 in both signals (left), RAP ≥ 0.6
in both signals (middle) and RAP ≥ 0.6 in one signal while RAP < 0.6 in another signal
(right)
PatID RAPSIGNAL 1 < 0.6/
RAPSIGNAL 2 < 0.6
RAPSIGNAL 1 ≥ 0.6/
RAPSIGNAL 2 ≥ 0.6
RAPSIGNAL 1 ≥ 0.6/RAPSIGNAL 2 < 0.6
or
RAPSIGNAL 1 < 0.6/RAPSIGNAL 2 ≥ 0.6
1 1,360 (73.5%) 369 (20%) 121 (6.5%)
2 910 (83.5%) 19 (1.7%) 161 (14.8%)
3 1,521 (32%) 2,776 (59%) 409 (9%)
4 1,371 (64.7%) 624 (29.4%) 124 (5.9%)
5 547 (33.1%) 1,017 (61.6%) 87 (5.3%)
6 652 (58%) 368 (33%) 99 (9%)
7 779 (24%) 2,148 (67%) 282 (9%)
8 45.6 (45%) 1,231 (32.9%) 809 (21.6%)
9 1,498 (35.5%) 2,051 (48.6%) 672 (15.9%)
10 2,800 (79.1%) 598 (16.9%) 140 (4%)
11 521 (34.9%) 891 (59.6%) 82 (5.5%)
12 323 (10.5%) 2,719 (88.0%) 47 (1.5%)
13 974 (70%) 217 (16%) 190 (14%)
14 1,349 (64.5%) 585 (28%) 159 (7.6%)
15 2,619 (47%) 2,425 (44%) 478 (9%)
16 1,798 (63.7%) 830 (29.4%) 196 (6.9%)
RAP: correlation coefficient (R) between the intracranial pressure (ICP) wave amplitude (A) and the mean ICP level (P).
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Figure 7 presents the correlation between percentages of BPEs of given magnitude
(5 mmHg ≤ BPE < 10 mmHg) and the percentage of 4-min periods with RAP difference
being ≥0.2 (Figure 7a), ≥0.4 (Figure 7b), and ≥0.6 (Figure 7c). The correlation plots
demonstrate that in patient recordings with a high percentage of BPEs, there is also a
high percentage of marked differences in RAP, i.e. the occurrences of differences in
RAP are associated with the occurrences of BPEs.Discussion
The main observation of this study was a marked difference in RAP indices [moving
correlation coefficient (R) between the ICP wave amplitude (A) and the ICP (P)]
obtained from simultaneous registrations from two separate, close-by ICP sensors of
the same type. The discrepancy in RAP between signals 1 and 2 was independent of
the use of a moving window with frequent updates. The occurrences of differences in
RAP were associated with occurrences of baseline pressure errors (BPEs). While the
number of patients was rather small (n = 16), the number of RAP observations was
high (total 43,653 4-min RAP observations and 1,727,000 6-sec RAP observations),
with a median number of RAP-observations for each patient (median 2,472).Clinical use of ICP-derived indices
ICP derived indices were introduced in the early 1990’s to enhance the diagnostic infor-
mation of ICP monitoring [6,12]. In particular, the RAP index has been used as a
possible indicator of the intracranial pressure volume compensatory reserve capacity
Table 4 Differences in 6-sec RAP-values between Signals 1 and 2
Pat ID N (6-sec RAP observations) Differences in RAP between Signals 1 and 2 (N,%)
0.2 0.4 0.6
1 73,005 18,935 (26%) 5,907 (8%) 1,981 (3%)
2 42,162 24,602 (58%) 13,710 (33%) 7,173 (17%)
3 206,708 17,604 (9%) 4,773 (2%) 1,793 (1%)
4 78,874 6,387 (8%) 938 (1%) 255
5 43,936 1,162 (3%) 250 (1%) 81
6 43,888 8,145 (19%) 2,288 (5%) 727 (2%)
7 126,768 8,545 (7%) 2,939 (2%) 1,205 (1%)
8 149,625 52,031 (35%) 31,938 (21%) 17,830 (12%)
9 167,244 37,871 (23%) 19,370 (12%) 11,763 (7%)
10 141,358 6,485 (5%) 1,015 (1%) 345
11 59,520 2,205 (4%) 527 (1%) 161
12 123,382 742 (1%) 127 57
13 54,411 15,663 (29%) 4,065 (7%) 1,069 (2%)
14 83,498 9,689 (12%) 2,793 (3%) 1,142 (1%)
15 220,276 31,022 (14%) 7,126 (3%) 1,677 (1%)
16 112,345 14,299 (13%) 2,657 (2%) 601 (1%)
RAP: correlation coefficient (R) between the intracranial pressure (ICP) wave amplitude (A) and the mean ICP level (P).
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patients with TBI [6,9,10,12,19] and in the diagnostic assessment of hydrocephalus
[7,8,11]; then proposing an upper normal threshold value of about +0.6 [6,8-11].
However, the clinical usefulness of this index remains to be determined [20-22].
In contrast, as compared to RAP scores derived from amplitudes computed using the
frequency domain method [6,12], we presently used an amplitude computed from the
time domain method (the MWA) [17]. The frequency- and time-domain methods for
calculating single pressure wave amplitudes are not equivalent [23]. The time domain
method has the advantage of correctly identifying the heartbeat-induced pressure waves
versus artifact waves. Using the frequency domain method, on the other hand, theFigure 5 Comparisons of methods 1 and 2 regarding percentage of observations with differences
in RAP ≥0.4 between signals 1 and 2. The percentages of RAP-differences ≥0.4 between signals 1
and 2 were determined for each patient using methods 1 (open boxes) and 2 (grey-shaded boxes).
The percentage for each individual is given within each box. The values are also given in Table 2
(Method 1) and 4 (Method 2).
Table 5 Proportion of 6-sec observations of RAP <0.6 in both signals (left), RAP ≥ 0.6 in
both signals (middle) and RAP ≥ 0.6 in one signal while RAP < 0.6 in another signal
(right)
Pat ID RAPSIGNAL 1 < 0.6/
RAPSIGNAL 2 < 0.6
RAPSIGNAL 1 ≥ 0.6/
RAPSIGNAL 2 ≥ 0.6
RAPSIGNAL 1 ≥ 0.6/RAPSIGNAL 2 < 0.6
or
RAPSIGNAL 1 < 0.6/RAPSIGNAL 2 ≥ 0.6
1 53,345 (73.1%) 14,269 (19.5%) 5,391 (7.4%)
2 35,400 (84.0%) 498 (1.2%) 6,264 (14.9%)
3 71,434 (34.6%) 114,056 (55.2%) 21,218 (10.3%)
4 51,401 (65.2%) 22,404 (28.4%) 5,069 (6.4%)
5 12,803 (29.1%) 29,420 (67.0%) 1,713 (3.9%)
6 25,215 (57.5%) 13,893 (31.7%) 4,780 (10.9%)
7 31,849 (25.1%) 85,127 (67.2%) 9,792 (7.7%)
8 69,759 (46.6%) 47,354 (31.6%) 32,512 (21.7%)
9 60,638 (36.3%) 80,763 (48.3%) 25,843 (15.5%)
10 112,598 (79.7%) 23,769 (16.8%) 4,991 (3.5%)
11 21,155 (35.5%) 35,341 (59.4%) 3,024 (5.1%)
12 12,949 (10.5%) 108,783 (88.2%) 1,650 (1.3%)
13 38,716 (71.2%) 8,457 (15.5%) 7,238 (13.3%)
14 54,390 (65.1%) 23,122 (27.7%) 5,986 (7.2%)
15 104,728 (47.5%) 94,725 (43.0%) 20,823 (9.5%)
16 71,439 (63.6%) 33,122 (29.5%) 7,784 (6.9%)
RAP: correlation coefficient (R) between the intracranial pressure (ICP) wave amplitude (A) and the mean ICP level (P).
Eide et al. BioMedical Engineering OnLine 2014, 13:99 Page 12 of 17
http://www.biomedical-engineering-online.com/content/13/1/99amplitude is retrieved from the first harmonic of the power spectrum, hence providing
an approximation of the amplitude [23]. In this present work, which compared RAP
values, the mode of amplitude computation should not affect the results.
It can be discussed how many data points that should be used for computation of
RAP. Most recent studies have determined RAP from 40 data points separated by 6 sec-
onds over 4 min periods [3,7-9,11]. We used the same approach in this present study.
Comparison of RAP scores from two simultaneous ICP signals
Combining the present RAP findings with those of an earlier study [16], differences in
RAP are smaller when comparing signals from similar ICP sensor types and larger
when comparing signals from different ICP sensor types [16]. The largest differences
were hence seen when monitoring from one solid - and one fluid ICP sensor.
The present findings extend our previous observations of marked differences in
4-min RAP when monitored simultaneously from two separate ICP sensors [16]. A
difference in 4-min RAP ≥0.4 was hence seen in ≥8% of observations in 5/16 (31%)
patients. Determining the proportion of 4-min observations wherein the RAP was ≥0.6
in one signal and <0.6 in another (above normal threshold level in one sensor and
below in the other) revealed this setting in >14% of scores in 4/16 (25%) patients and
>9% of scores in another 4/16 (25%) patients. The combination of above normal
threshold level in one sensor and below in the other is of particular importance because
it carries the potential to change the clinical decision making process.
Determining the RAP every 4 min period (presently referred to as method 1) carries
the potential risk of introducing high variability in the recorded value. In an attempt to
Figure 6 Comparisons of methods 1 and 2 regarding percentage of observations with discrepancy
in RAP </≥0.6 between signals 1 and 2. The percentages of observations wherein one signal showed
RAP ≥0.6 while the other showed RAP <0.6 were determined for each patient using methods 1 (open boxes)
and 2 (grey-shaded boxes). The percentage for each individual is given within each box. The values are also
given in Table 3 (Method 1) and 5 (Method 2).
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with updates every 5-10 seconds [18]. Incorporating such a moving time window with
updates every 5-10 seconds means that the ‘oldest’ averaged value drops out and the
‘newest’ drops in, thereby slightly altering the Pearson correlation coefficient every 5-10
seconds. Presently we have shown that incorporating such a moving time window with
frequent updates of RAP (method 2) do not reduce the discrepancy in RAP between
the two signals, as compared to updating the RAP every 4-min period (method 1).
Another approach to reduce the variability in RAP is to average scores over a long
time period, e.g. 20-30 min. However, averaging scores works as filtering of the calcu-
lated values, and has the drawback of hiding information. Averaging over long time
periods will thus extensively mask differences in RAP. This can be seen in Table 2, left,
where the average of RAP scores over many hours of recording reveals only minor
differences in the RAP. From a clinical perspective, such multi-hour average values are
of limited interest. Since RAP is recommended for use in the surveillance of critically
ill patients, short-term updates of RAP would be needed. Averaging over 20-30 minute
periods has hence less relevance since marked clinical deterioration may happen over
such long periods.
Obviously, it can be disputed which differences in RAP that have clinical significance.
In this context, it should be remembered that ICP and ICP-derived indices such as
RAP are used in the surveillance of critically ill patients. An erroneous measurement
revealed to the physician/nurse may represent potential harm to the patient. In this
present study cohort, one ICP sensor showed RAP >0.6 while the other showed RAP
<0.6 in about 1/10 observations (9-14%) in 8/16 patients. Given the diagnostic import-
ance of such an index in patient management, we consider such a difference of clinical
significance.
In the present patients, ICP monitoring was done as part of patient surveillance.
Therefore, monitoring was independent whether the EVD was open or closed, and
independent the opening pressure of the EVD. Since the ICP sensors were placed close
by within the brain, both ICP sensors would be similarly impacted independent of
drainage through the EVD.
The RAP should be considered together with the mean ICP since RAP may become
de-coupled from the mean ICP when mean ICP is very high (>20-40 mmHg) [12]. It
should be noted that mean ICP of the patients presented here was well below
20 mmHg, as recently reported for this same patient material [15].
Figure 7 (See legend on next page.)
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Figure 7 Correlation plots of percentages of baseline pressure errors (BPEs) and RAP [correlation
coefficient (R) between the intracranial pressure (ICP) wave amplitude (A) and the mean ICP level
(P)]-differences. The percentages of RAP-differences are plotted against the percentages of BPEs of various
magnitudes for the 16 patients of the study. The percentages of BPEs of magnitudes ≥5 mmHg/<10 mmHg
were plotted against differences in RAP of (a) ≥0.2 or (b) ≥0.4, and (c) ≥0.6. The Spearman correlation
coefficients are given suggesting significant correlation between percentages of BPEs and percentages
of RAP-differences. The plots were created based on percentages provided in Table 4.
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In 2006 Eide [13] described the phenomenon of baseline pressure errors (BPEs)
when monitoring ICP simultaneously from two separate ICP sensors. The BPEs were
manifested as marked differences in mean ICP combined with close to identity in
ICP wave parameters such as the MWA [13]. In subsequent studies, BPEs could
explain the differences in mean ICP observed when the two sensors were placed in
different intracranial compartments [24,25]. By monitoring simultaneously from two
separate ICP sensors, we have observed BPEs in solid sensors (Codman), air-pouch
sensors (Spiegelberg) and fluid sensors (Edward’s Life science) [14]; indeed, BPEs
have been observed in every type of ICP sensors tested, the Raumedic Neurovent P
[26,27], the Codman [28], the Camino [29] and the Spiegelberg [30] sensor. Our
recent prospective observational study has confirmed that BPEs occur frequently in
the clinical setting, and can be of a magnitude that may affect clinical management [15].
BPEs may also explain the abrupt shifts and drifts in the relationship between mean ICP
and MWA that are observed when monitoring using merely one ICP sensor [31].
In an experimental study, Eide and Bakken [32], showed that solid ICP sensors are
sensitive to electrostatic discharges (ESDs) and observed BPEs in the form of sudden
pressure shifts. Pressure drifts were thus seen following ESDs. The BPEs were of a
magnitude that could alter patient management in a clinical setting given similar
changes in mean ICP. This observation has recently been confirmed by others [33].
The cause of BPEs may be different when recording from a fiber-optic ICP sensor, a
solid sensor based on the whetstone bridge principle, or from an air-pouch type of ICP
sensor. All technical components of an ICP monitoring system (sensor, cable, trans-
ducer, display) represent potential sites of origin of BPEs. When monitoring ICP
through an EVD, BPEs may in addition be created by imperfect fluid connection caused
by air bubbles and debris, or through movement of the sensor position (height) relative
to the measurement site [14].Impact of BPEs on ICP-derived indices
As illustrated in Figure 1, the BPEs were revealed as marked differences in mean ICP
combined with close to identical ICP waveform. The largest differences in RAP were
seen in patients 2, 3, 6, 7, 8, 9, 13, and 15 (Table 3). In these very same patients, there
was also a high frequency and severity of BPEs.
Given that BPEs cause alterations in mean ICP, it is to be expected that every pres-
sure index wherein the mean ICP is incorporated also becomes affected. However, the
differences in RAP are less pronounced than the differences in mean ICP. This is
because the RAP also incorporates the ICP amplitude, which is resistant to BPEs. For
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reactivity index (PRx), which is the moving correlation between mean ICP and mean
arterial blood pressure (mean ABP) [34], can be anticipated to be particularly suscep-
tible to BPEs.
Due to the effect of BPEs on the RAP indices, its feasibility as a guide in the manage-
ment of neurosurgical patients will be hampered. In our opinion, the divergence in
RAP from the two sensors is of such an extent that we do not advocate the use of RAP
in clinical practice. In contrast, since the ICP wave amplitude is unaffected by BPEs,
the ICP wave amplitude is a robust parameter. Thus, in a recent study comparing the
ICP wave amplitude, ICP wave slope, and RAP as measures of intracranial compliance
in head injury patients, the ICP wave amplitude was found to be superior to the other
parameters [21].
Conclusions
Simultaneous monitoring from two separate, close-by ICP sensors reveals significant
differences in RAP that correspond to the occurrence of BPEs. As differences in RAP
are of magnitudes that may alter patient management, we do not advocate the use of
RAP as a guide in the management of neurosurgical patients.
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